August 1, 1995Journal of Hypertension
Complications and survival of 315 patients with malignant-phase hypertension
Population
315 patients with malignant-phase hypertension
Design
Cohort
Follow-up
5 years
Authors
Discussion
Loading...
Member takes
Implication
Persistent mortality and racial disparities in malignant hypertension underscore need for earlier detection; leaves open whether targeted strategies improve outcomes.
Structured PICO
P
Population
315 patients with malignant-phase hypertension
O
Outcome
Survival (progression to death or chronic renal haemodialysis)hard clinical
Malignant hypertension has a 5-year survival of 74% with modern therapy, though black patients have a worse prognosis due to late presentation and renal impairment.
Cite This Study
Lip et al. (1995) studied this question.